News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Intratumoral, pembrolizumab and mRNA-2752 for high-risk Ductal Carcinoma In Situ
Jan 21, 2025, 05:12

Intratumoral, pembrolizumab and mRNA-2752 for high-risk Ductal Carcinoma In Situ

Kristina Jankovic, Medical Oncology Resident at University Clinical Center Nis, shared a post on X:

“Intratumoral, pembrolizumab and mRNA-2752 for high-risk DCIS : Phase 1 nonrandomized trial

80% response rate
no major systemic toxicities
complete tumor resolution in some possible surgery reduction
Ongoing studies needed.”

Intratumoral Injection of mRNA-2752 and Pembrolizumab for High-Risk Ductal Carcinoma In SituA Phase 1 Nonrandomized Clinical Trial

Authors: Kirithiga Ramalingam, Rachel Woody, Alexa Glencer

Intratumoral, pembrolizumab and mRNA-2752 for high-risk Ductal Carcinoma In Situ

Alexa Glencer cancer Kirithiga Ramalingam Kristina Jankovic OncoDaily Oncology Rachel Woody
Special Coverage
Voices
Aug 25, 2025, 16:30
Sarcoma 101 at Fellowship Bootcamp with Steve Bialick - Miami Hematology Oncology Program Director
Science
Aug 25, 2025, 16:04
George Kumar Shares Breakthrough in Cold Plasma Oncology
Voices
Aug 25, 2025, 15:59
Cancer Research Institute Highlights Its Role in Immune-Based Cancer Breakthroughs
Voices
Aug 25, 2025, 15:59
Al-Ola Abdallah Shares Inspiring Patient Recoveries in Myeloma Clinic
Societies
Aug 25, 2025, 15:59
Join AORTIC-Africa for Expert Insights on Lung Cancer Radiotherapy
Voices
Aug 25, 2025, 15:58
Need For Supportive Care Has Grown Exponentially - Union for International Cancer Control
Insight
Aug 25, 2025, 15:58
John Gordon: ACTIVATE Platform Enhances Adoptive Cell Therapy for Solid Tumors
Voices
Aug 25, 2025, 15:57
Françoise Meunier Supports Shorter ‘Right to Be Forgotten’ Period for Cancer Survivors
Voices
Aug 25, 2025, 15:56
Exploring How ADCs Enhance Anti-Tumor Immunity - Society for Immunotherapy of Cancer
Science
Aug 25, 2025, 15:56
Vincent Rajkumar Highlights New Guidance for Managing AML in the Elderly Patients
Voices
Aug 25, 2025, 15:56
Cynthia Jordan Highlights Breast Cancer Risks for Military Women
Insight
Aug 25, 2025, 15:55
Savino Cilla Shares a Study to Underscore the Complexity of Prognostic Modeling in Salvage RT